Bioprogress Future2

Getting back to the acquisition and fundraising.

We gave £5.4m (E8m) cash to Dexo. Then turned around to issue 12m shares at 47p which raises £5.7m which effectively just gets our money back. Why not just give Dexo all the share in the first place which would have been at 52p instead of 47p which is a better deal for shareholders, and it's does away with the cut that the broker normally takes too. RT and DF are both smart numbers guys so why do it this way???? Still happy with the outcome but just curious as to the structure of the deals. Any possible explanations?

Inghu